Battelle/BIO State Bioscience Initiatives 2010
The bioscience sector has continued to create jobs even in the midst of recession, Battelle/BIO finds in its annual State Bioscience Initiatives report.
"Not every biotech company made it through the storm. Fifty publicly traded companies went bankrupt for lack of access to capital. But there is much good news. Biotech stocks outperformed virtually every other index in the first quarter of this year. The markets have come back but Biotech has come back faster and stronger," said Jim Greenwood, president and CEO of BIO.
While total private sector employment dropped 0.7 percent from 2007-2008, bioscience employment grew by 1.4 percent. Research, testing, and medical laboratories account for more than 176,000 jobs added from 2001-2008, representing nine of 10 new bioscience jobs created during that time.
States are taking advantage of this growth by investing in major bioscience initiatives; focusing on agricultural biotech and bioenergy; and implementing tax programs favorable to bio companies.
RespirTek Consulting Laboratory Builds Headquarters & Research Hub in Jackson County, Mississippi
How are Uncertain Times Altering Company Location Strategies?
Infrastructure Investment as an Economic Stimulus Tool
2020 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
Site Selection 2020: The Importance of “Regional Depth” with Global Reach
34th Annual Corporate Survey & the 16th Annual Consultants Survey
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row